HMA's Shareholder Battle Intensifies
This battle with Glenview comes on the heels of several other recent challenges for HMA.
In December 2012, CBS' "60 Minutes" aired a story in which former HMA employees accused the company of admitting patients for the sake of revenue rather than medical necessity. The company denies the allegations.
In May, HMA ratified a "poison pill"—a legal maneuver designed to thwart a hostile takeover by a large stakeholder—to prevent Glenview from seizing control of the company. Glenview has also filed documents with the SEC requesting that HMA amend the poison pill.
Also in May, president and CEO Gary D. Newsome announced plans to retire at the end of July to head a religious program in South America.
- Ratcheting Up Patient Experience Has a Downside
- Narrow Networks Enjoying a Resurgence
- 'Mega Boards' Could be Rural Healthcare Disruptor
- 12 Hires to Keep Your Hospital Out of Trouble
- Meaningful Use Payment Adjustments Begin
- HL20: Lee Aase—Who's Behind @MayoClinic
- HL20: Anne Wojcicki—Unlocking Consumer Access to Genetics
- Taming Time and Moving Healthcare Data
- Christmas Tree Syndrome Season Underway
- Physicians Trained in High-Cost Regions Spend More